Search Results 121-130 of 17421 for Mmol

1. Biobank Protocol, Rare Diseases Clinical Research Network - Mayo Clinic

   Urinary oxalate excretion of greater than 0.8 mmol/1.73 m2 ... Two or more 24 hour urine collections in the year prior to enrollment with oxalate > 0.6mmol ...

2. Myelofibrosis - Doctors and departments - Mayo Clinic

   Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.

3. Meet the investigator: Roxana S. Dronca, M.D. - Mayo Clinic Comprehensive Cancer Center Blog

   At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story.

4. Baxdrostat in Uncontrolled Hypertension on Two or More Medications Including Resistant Hypertension - Mayo Clinic

   ... mmol/L at Screening * Randomisation Criterion: * Sitting systolic blood pressure on attended automated office blood pressure measurement of ≥ 135 mmHg at ...

5. A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia - Mayo Clinic

   - Fasting TG ≥ 500 mg/dL (5.65 mmol/L) at Screening and Qualification. - Patients must be on lipid-lowering therapy that should adhere to standard of care ...

6. Graduate Outcomes - Meet Our Students - Medical Scientist Training Program (M.D.-Ph.D.) - Mayo Clinic College of Medicine & Science

   Graduate outcome information for the M.D.-Ph.D. program in Mayo Clinic Graduate School of Biomedical Sciences.

7. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

   Potassium < 3.7 mmol/l or > 5.5 mmol/l at screening. Severe renal impairment (creatinine clearance < 30 ml/min at screening), creatinine > 170 μmol/l at ...

8. Encaleret Compared to Standard of Care in Participants with Autosomal Dominant Hypocalcemia Type 1 - Mayo Clinic

   Participation eligibility · cCa < 8.6 mg/dL (2.2 mmol/L) in participants 16 to < 18 years, or < 8.5 mg/dL (2.1 mmol/L) in participants ≥ 18 years iPTH < 40 pg/ ...

9. A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients with Mayo Stage IIIa AL Amyloidosis

   Hypercalcemia: serum calcium \> 0.25 mmol/L (\> 1 mg/dL) higher than the upper limit of normal (ULN) or \> 2.75 mmol/L (\> 11 mg/dL) OR ii. Renal ...

10. A Study to Explore Quality of Life According to Treatment Plan for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

    Participation eligibility · (C) Calcium elevation in blood. Serum calcium >1mg/dL (>0.25mmol/L) higher than the upper limit of normal or >11mg/dL (>2.75mmol/L).